Recently, the Jiangsu Provincial Department of Human Resources and Social Security issued the "Notice on the Implementation of the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition)" (hereinafter referred to as the Notice). The "Notice" is clear and officially implemented on September 1. The 2017 version of the National Health Insurance Drug List, before the implementation of the new version in Jiangsu Province, the drugs in the 2010 edition of the drug list that are not included in the 2017 edition of the Category B drug (including compound drugs) continue to be used, except for the varieties that were deleted during the 2017 revision of the catalogue. This means that the province's 2010 edition of supplements will continue to be used during this period.
Regarding the authority of the medical insurance co-ordination area, the "Notice" proposes that local-level cities can formulate individual self-pay ratios according to the ability of local funds to bear, which is consistent with the national opinion. In the future, each medical insurance co-ordination area (generally a prefecture-level city) will personally provide medical insurance. The proportion of self-pay and fund commitment will affect the use and reimbursement of Class B drugs.
It is worthy to pay special attention to the fact that the "Notice" requires all localities to set a certain amount of personal self-pay according to the ability of the fund, and the proportion of personal self-paying of the class B drugs, and the social security of human resources in each district and city. The bureau formulated it in a unified manner and reported it to the provincial government for the record. For drugs that are mainly used as ancillary treatment or easy to abuse, it is necessary to increase the proportion of personal self-pay and increase the proportion of payment with other Class B drugs. This means that drugs that are easy to abuse are being “suppressed†by Jiangsu Medical Insurance. The restrictions on this variety may be further increased.
Finally, the "Notice" said that the new drug database should be improved: the province will uniformly review the declared varieties and maintain the drug information, and improve the drug catalog database, and issue it to the local authorities before the end of August.
Micro-prismatic Reflective Tape
Diamond Reflective Tape,Transparent Reflective Tape,Diamond Grade Reflective Tape,Diamond Grade Reflective Sheeting
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytapes.com